Related Experiment Video
Updated: Aug 13, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Increased malondialdehyde levels in coronary heart disease
Insights
Coronary heart disease patients exhibit elevated lipid peroxidation, indicated by higher malondialdehyde levels. Smoking further exacerbates this lipid peroxidation in patients with coronary heart disease.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Oxidative Stress Research
Background:
- Lipid peroxidation is a key process in oxidative stress.
- Oxidative stress is implicated in the development of cardiovascular diseases.
- Understanding lipid peroxidation markers is crucial for assessing cardiovascular disease risk.
Purpose of the Study:
- To compare lipid peroxidation status between coronary heart disease (CHD) patients and healthy controls.
- To investigate the impact of smoking on lipid peroxidation in CHD patients.
Main Methods:
- Serum levels of malondialdehyde (MDA), total cholesterol, triglycerides, HDL-C, and LDL-C were measured.
- The study included 46 CHD patients and 50 age-matched healthy controls.
- CHD patients were stratified into smokers and non-smokers to assess smoking's effect.
Main Results:
- CHD patients showed significantly higher MDA and lipid parameters (except HDL-C, which was lower) compared to controls (P < 0.001).
- Smokers with CHD had significantly higher MDA levels than non-smokers with CHD (P < 0.025).
Conclusions:
- Elevated serum MDA suggests increased oxygen free radical production in CHD.
- These findings support a role for oxidative stress and lipid peroxidation in atherogenesis and CHD development.
- Smoking appears to augment lipid peroxidation in individuals with coronary heart disease.
Objective:
To assess and compare the status of lipid peroxidation, both in control subjects and in coronary heart disease patients.
Methods:
Serum total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and malondialdehyde levels were determined in 46 patients with coronary heart disease and 50 age matched control healthy subjects. 29 male coronary heart disease patients were divided into smoker (n = 19) and nonsmoker (n = 10) groups, to observe the effect of smoking on lipid peroxidation in coronary heart disease patients.
Results:
Malondialdehyde and lipid parameters were found significantly high (P < 0.001) with the exception of high-density lipoprotein cholesterol which was significantly low (P < 0.001) in coronary heart disease patients. Smokers with coronary heart disease showed significantly increased (P < 0.025) malondialdehyde levels as compared to nonsmokers with coronary heart disease.
Conclusion:
Elevated serum levels of malondialdehyde indicate increase in the level of production of oxygen free radicals, suggesting their possible role in atherogenesis, leading to coronary heart disease.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction

